Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24249| Title: | A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG) |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Aged, 80 and over,*Antineoplastic Agents/adverse effects/therapeutic use,*Aziridines/adverse effects/therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Humans,*Indolequinones,*Indoles/adverse effects/therapeutic use,Injections, Intravenous,Lung Neoplasms/*drug therapy/pathology,Male,Middle Aged,Survival Rate,Treatment Outcome |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/24249 |
| ISSN: | 0923-7534 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/8839911 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pavlidis-1996-a randomized phase.pdf | 204.22 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
